1Sacco RL,Mayer SA.Epidemiology of intracerebral hemorrhage.In:Feldmann E,ed.Intracerebral hemorrhage.Armonk,NY:Futura Publishing Co,1994.3-23.
2Antoni Davalos,Marc Fisher.Emerging therapies for cerebrovascular disorders.Stroke,2005,34(2):208-210.
3Asif A.Siddiqui and Lesley J.Scott M.Recombinant factor Ⅵ-Ia:A review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.Drugs,2005,65 (8):1161-1177.
4Hoffman M,Monroe DM.The activation of high-dose factor Ⅵ-Ia in a cell-based model of hemostasis.Dis Mon,2003,49(1):14.
5Hedner U,Ljundberg J,Lund-Hansen T.Comparison of the effect of plasma-derived and recombinant human FⅦa in vito and in a rabbit mode.Blood Cogul Fibrinolysis,1990,1 (2):145.
6Veldman A,Hoffman M,Ehrenforth S.New insights into the coagulation system and implication for new therapeutic options with recombinant factor Ⅶa.Curr Med Chem,2003,10(10):797.
7Brott T,Broderick J,Kothari R,et al.Early hemorrhage growth in patients with intracerebral hemorrhage.Stroke,1997,28(1):1-5.
8Maye SA.Ultra-early hemostatic therapy for intracerebral hemorrhage.Stroke,2003,34(1):224-229.
9Brott T,Broderick J,Kothari R,et al.Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke,1997,28(1):1-5.
10Fujii Y,Takeuchi S,Sasaki O,et al.Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage.Stroke,1998,29(6):1160-1166.
